Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy.

Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy.

BACKGROUND: The purpose of this work was to determine the clinical and hemodynamic correlates of alterations in cardiac high-energy phosphate metabolism in patients with aortic stenosis and with aortic incompetence. METHODS: Fourteen volunteers, 13 patients with aortic stenosis, and 9 patients with...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Neubauer, S, Horn, M, Pabst, T, Harre, K, Strömer, H, Bertsch, G, Sandstede, J, Ertl, G, Hahn, D, Kochsiek, K
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	1997

Míreanna comhchosúla

[Cardiac energy metabolism in heart valve diseases with 31P MR spectroscopy]
de réir: Beer, M, et al.
Foilsithe / Cruthaithe: (2000)

Changes in left and right ventricular cardiac function after valve replacement for aortic stenosis determined by cine MR imaging.
de réir: Sandstede, J, et al.
Foilsithe / Cruthaithe: (2000)

Cardiac systolic rotation and contraction before and after valve replacement for aortic stenosis: a myocardial tagging study using MR imaging.
de réir: Sandstede, J, et al.
Foilsithe / Cruthaithe: (2002)

Determination of absolute concentrations of cardiac highenergy phosphates using 31P-MR-spectroscopy and SLOOP in healthy and diseased myocardium
de réir: Beer, M, et al.
Foilsithe / Cruthaithe: (1999)

Advances in human cardiac 31P-MR spectroscopy: SLOOP and clinical applications.
de réir: von Kienlin, M, et al.
Foilsithe / Cruthaithe: (2001)

Absolute levels of cardiac high-energy phosphate metabolites in human heart failure and left ventricular hypertrophy - Non-invasive measurements by P-31-SLOOP MRS
de réir: Beer, M, et al.
Foilsithe / Cruthaithe: (2000)

Cardiac 31P-MR-spectroscopy in myocardial insufficiency
de réir: Krahe, T, et al.
Foilsithe / Cruthaithe: (1993)

Altered energy metabolism after myocardial infarction assessed by 31P-MR-spectroscopy in humans.
de réir: Beer, M, et al.
Foilsithe / Cruthaithe: (2000)

31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease: Altered cardiac high-energy phosphate metabolism in heart failure
de réir: Neubauer, S, et al.
Foilsithe / Cruthaithe: (1992)

[The quantification of energy-rich phosphates in healthy and damaged heart muscle by SLOOP 31P-MR spectroscopy. Spatial localization with optimal pointspread function]
de réir: Beer, M, et al.
Foilsithe / Cruthaithe: (1999)

Absolute concentrations of cardiac high-energy phosphate metabolites ATP and phosphocreatine in heart failure: Relation to clinical severity and left ventricular function
de réir: Beer, M, et al.
Foilsithe / Cruthaithe: (2001)

Clinical cardiac magnetic resonance spectroscopy--present state and future directions.
de réir: Neubauer, S, et al.
Foilsithe / Cruthaithe: (1998)

Assessment of myocardial viability by 31P-MR-spectroscopy and 23Na-MR imaging.
de réir: Beer, M, et al.
Foilsithe / Cruthaithe: (2000)

31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure.
de réir: Neubauer, S, et al.
Foilsithe / Cruthaithe: (1992)

Changes of myocardial high-energy phosphates with the cardiac cycle during acute or chronic myocardial stress.
de réir: Illing, B, et al.
Foilsithe / Cruthaithe: (1998)

Contributions of 31P-magnetic resonance spectroscopy to the understanding of dilated heart muscle disease.
de réir: Neubauer, S, et al.
Foilsithe / Cruthaithe: (1995)

(31)P-MR Spectroscopy for the evaluation of energy metabolism in intact residual myocardium after acute myocardial infarction in humans.
de réir: Beer, M, et al.
Foilsithe / Cruthaithe: (2001)

Concentration of human cardiac 31P-metabolites determined by SLOOP 31P-MRS.
de réir: Landschütz, W, et al.
Foilsithe / Cruthaithe: (1998)

Cine MRI for the evaluation of influences of regional left ventricular wall motion abnormalities on global cardiac function after myocardial infarction and revascularization therapy
de réir: Sandstede, J, et al.
Foilsithe / Cruthaithe: (1999)

Concentrations of human cardiac phosphorus metabolites determined by SLOOP 31P NMR spectroscopy.
de réir: Meininger, M, et al.
Foilsithe / Cruthaithe: (1999)

[Magnetic resonance spectroscopy of the heart. Its clinical importance]
de réir: Neubauer, S, et al.
Foilsithe / Cruthaithe: (1993)

Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy.
de réir: Beer, M, et al.
Foilsithe / Cruthaithe: (2002)

Deterioration of metabolic coronary regulation in hemorrhagic shock. Role of hypoxia and the renin-angiotensin system.
de réir: Ertl, G, et al.
Foilsithe / Cruthaithe: (1985)

Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.
de réir: Neubauer, S, et al.
Foilsithe / Cruthaithe: (1997)

Temporal fluctuations of myocardia high-energy phosphate metabolite with the cardiac cycle.
de réir: Spindler, M, et al.
Foilsithe / Cruthaithe: (2001)

Three-dimensional 31P magnetic resonance spectroscopic imaging of regional high-energy phosphate metabolism in injured rat heart.
de réir: von Kienlin, M, et al.
Foilsithe / Cruthaithe: (1998)

[31P-cardio-MR-spectroscopy in myocardial insufficiency]
de réir: Krahe, T, et al.
Foilsithe / Cruthaithe: (1993)

Absolute quantification of high energy phosphate metabolites in normal, hypertrophied and failing human myocardium.
de réir: Neubauer, S, et al.
Foilsithe / Cruthaithe: (2000)

Magnetic resonance imaging of the heart
de réir: Neubauer, S, et al.
Foilsithe / Cruthaithe: (1993)

[In vivo 31P-cardiac magnetic resonance spectroscopy: methods and the first clinical results]
de réir: Krahe, T, et al.
Foilsithe / Cruthaithe: (1991)

PPAR alpha is involved in triiodothyronine-induced cardiac hypertrophy and high-energy phosphate metabolism: A P-31 MRS study of the PPAR alpha-null mouse
de réir: Zhang, W, et al.
Foilsithe / Cruthaithe: (2006)

In vivo 31P cardiac nuclear magnetic resonance spectroscopy. Methods and first clinical results
de réir: Krahe, T, et al.
Foilsithe / Cruthaithe: (1991)

Elucidation of cardiac physiology in aortic valve replacement: what should we know?
de réir: Jin, X
Foilsithe / Cruthaithe: (2004)

PERIOPERATIVE ASSESSMENT OF AORTIC HOMOGRAFT, TORONTO STENTLESS VALVE, AND STENTED VALVE IN THE AORTIC POSITION
de réir: Jin, X, et al.
Foilsithe / Cruthaithe: (1995)

Perioperative assessment of aortic homograft, Toronto stentless valve, and stented valve in the aortic position.
de réir: Jin, X, et al.
Foilsithe / Cruthaithe: (1995)

Mechanics of aortic heart valve
de réir: Lim, Hou Sen
Foilsithe / Cruthaithe: (2008)

Aortic dilation in bicuspid aortic valve disease: flow pattern is a major contributor and differs with valve fusion type.
de réir: Bissell, M, et al.
Foilsithe / Cruthaithe: (2013)

Analysis of first-pass and delayed contrast-enhancement patterns of dysfunctional myocardium on MR imaging: use in the prediction of myocardial viability.
de réir: Sandstede, J, et al.
Foilsithe / Cruthaithe: (2000)

Time course of contrast enhancement patterns after Gd-BOPTA in correlation to myocardial infarction and viability: a feasibility study.
de réir: Sandstede, J, et al.
Foilsithe / Cruthaithe: (2001)

[CINE-MRT for the study of the effects of regional left ventricular wall motion disorders on global heart function after a myocardial infarct and revascularization]
de réir: Sandstede, J, et al.
Foilsithe / Cruthaithe: (1999)